((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

New funding from Biocurate will support a Monash University project that's developing a novel disease-modifying treatment for ...

Crown Princess Mette-Marit of Norway is on sick leave due to medicinal side effects associated with her chronic lung disease, ...

Tyr Pharma has a pivotal year ahead with key readouts for Efzofitimod, potentially opening a huge market. Find out why ATYR ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

Life challenges make this population very difficult to treat, but interventions that take their issues into account may ...

New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi ...

Researchers studied 20 patients who were assigned to 12 weeks of supplemental oxygen for 16 or more hours a day or no oxygen ...

Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

Tectonic Therapeutic's lead candidate TX45 showed positive phase 1 results for Group 2 Pulmonary Hypertension. Read why I ...

As the pollution increases, the doctor said, the number of attacks related to respiratory problems is also multiplying, due ...